Perceptive Advisors - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 74 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,648,000
-53.9%
750,000
-4.8%
0.08%
-7.2%
Q3 2021$5,743,000
-63.6%
787,745
-50.0%
0.08%
-19.4%
Q2 2021$15,786,000
+109.8%
1,575,490
+100.0%
0.10%
+8.4%
Q1 2021$7,523,000
-12.9%
787,7450.0%0.10%
+2.2%
Q4 2020$8,642,000
+23.7%
787,7450.0%0.09%
-8.8%
Q3 2020$6,987,000787,7450.10%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$10,454,0001.67%
Boxer Capital, LLC 1,251,055$12,536,0000.44%
Pentwater Capital Management LP 4,967,227$49,772,0000.41%
KNOTT DAVID M 29,566$296,0000.10%
Perceptive Advisors 1,575,490$15,786,0000.10%
Virtus ETF Advisers LLC 24,287$243,0000.10%
Advisory Services Network, LLC 256,772$2,573,0000.08%
J. Goldman & Co LP 202,501$2,029,0000.08%
Ikarian Capital, LLC 85,837$861,0000.07%
Regent Investment Management LLC 25,000$251,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders